Moreover, this study showed the requirement of SOX2 for OS formation and survival of the tumor cells, proposing that disruption of these pathways initiated by SOX2 is an attractive strategy for the treatment of OS [89,90]. The gene discussed is SOX2; the disease is neoplasm.